Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus
Journal
International journal of antimicrobial agents
Journal Volume
60
Journal Issue
5-6
Date Issued
2022
Author(s)
Su, Yi-Ching
Liu, Wen-Chun
Abstract
Data on the effectiveness of tenofovir alafenamide (TAF) against lamivudine-resistant (LAM-R) hepatitis B virus (HBV) among patients co-infected with human immunodeficiency virus (HIV) and HBV are limited.
Subjects
Antiviral resistance; Hepatitis B virus envelope antigen; Hepatitis B virus surface antigen; Nucleos(t)ide analogue; Seroconversion; Tenofovir alafenamide
SDGs
Type
journal article